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INTRODUCTION
Mitral valve (MV) repair is widely regarded as the 
procedure of choice for significant non-rheumatic mitral 
regurgitation (MR) requiring surgery. Operative risks and 
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Objective: We aimed to investigate the diagnostic accuracy of cardiac computed tomography (CT) for the detection of 
mitral valve (MV) prolapse in mitral regurgitation (MR) with surgical findings as the standard reference, and to assess the 
predictability of MV replacement based on morphologic CT findings.
Materials and Methods: A total of 156 patients who had undergone preoperative cardiac CT and subsequently received MV 
surgery due to severe MR were retrospectively enrolled. Non-repairable MV was defined when at least one of the following 
conditions was met: 1) anterior leaflet prolapse, 2) bi-leaflet prolapse, or 3) valve morphology (leaflet thickening, 
calcification, or mitral annular calcification [MAC]). Diagnostic performance of CT for the detection of the prolapsed segment 
was assessed with surgical findings as the standard reference. Logistic regression analysis was performed to evaluate the 
value of CT findings to predict actual valve replacement. 
Results: During surgery, MV prolapse was identified in 72.1%. The sensitivity, specificity, and diagnostic accuracy for the 
detection of MV prolapse were 99.1%, 81.4%, and 94.2%, respectively, per patient. One-hundred eighteen patients (75.6%) 
underwent MV repair and the remaining 38 patients received MV replacement. Bi-leaflet prolapse and valve morphology 
were independent predictors of valve replacement after adjusting for clinical variables (adjusted odds ratio, [OR] 8.63 for 
bi-leaflet prolapse; OR, 4.14 for leaflet thickening; and OR, 5.37 for leaflet calcium score > 5.6; p < 0.05).
Conclusion: Cardiac CT can have high diagnostic performance for detecting the prolapsed segment of the MV and predictability 
of valve replacement before surgery. Bi-leaflet prolapse and valve morphology, such as leaflet thickening, or calcification or 
MAC, are the most important predictors of valve replacement.
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outcomes are better for patients undergoing MV repair 
versus MV replacement in patients with MR who have valve 
morphology suitable for repair (1-3). Although the rate 
of MV repair over MV replacement has been increasing, 
a number of patients with primary MR will still undergo 
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MV replacement (4). The feasibility of MV repair depends 
not only on the pathology or morphology, but also on 
the experience of the surgeon and/or the valve team, and 
sometimes it is very challenging (5, 6). Generally, the 
success rate of MR with isolated posterior leaflet prolapse 
reaches almost 100%; in contrast, repair of the anterior 
leaflet or bi-leaflet prolapse is technically more demanding 
and associated with worse outcomes (7-11). Moreover, 
leaflet restriction with thickening and/or calcification, 
which can be frequently seen in rheumatic heart disease, 
is considered less suitable for repair (12). In addition, 
severe mitral annular calcification (MAC) is associated 
with increased complications following MV surgery and 
intraoperative conversion from MV repair to replacement 
(13-16).
Appropriate selection of a repairable valve is critical to 
preoperative planning because of recurrent MR, which is 
the most common cause of MV repair failure and usually 
develops after the repair of a non-repairable valve in the 
initial surgery (11, 17, 18). Recurrent MR is related to 
adverse outcomes such as reoperation, heart failure, and 
cardiac death (19). Moreover, conversion from MV repair 
to replacement in the surgical field may result in a longer 
operation time (20). 
Transthoracic echocardiography (TTE) can provide 
information about the MV, not only in the assessment of 
the mechanism and severity of MR, but also in quantifying 
the hemodynamic consequences of MR as determined by 
left ventricular (LV) size and function, left atrial size, 
and pulmonary artery pressure. TTE has been reported 
to have high diagnostic performance for detecting the 
prolapsed segment of the MV, which is a common finding 
in degenerative MR (21). Moreover, TTE can provide 
information about valve morphology such as thickening 
or calcification of a leaflet or the subvalvular apparatus. 
However, TTE may have limited value in patients with a 
poor echo window. Cardiac computed tomography (CT) 
has the advantage of excellent spatial resolution and 
recently received attention regarding its comprehensive 
anatomic evaluation of the MV complex and morphological 
abnormalities (22). A few previous studies have investigated 
the utility of cardiac CT in MV disease, most of which 
have focused on the diagnostic performance of CT for the 
detection of MV prolapse (23-26). CT can also be used for 
the geometric assessment of the MV leaflet, annulus, and LV 
remodeling to help determine the mechanism of functional 
MR (27). Therefore, we hypothesized that cardiac CT can 
help evaluate valve morphology and predict MV replacement 
in patients with severe MR.
We aimed to investigate the diagnostic accuracy of 
cardiac CT for the detection of MV prolapse in severe MR 
with surgical findings as the standard reference and to 
assess the ability of CT findings regarding morphologic 
evaluation to predict MV replacement.
38 patients who underwent
MV replacement
Inclusion criteria (n = 220)
•  Underwent cardiac CT from January 2014 to 
November 2016
•  Severe (grade 4) MR on echocardiography
156 patients included
118 patients who underwent
MV repair
Exclusion criteria
•  37 patients who did not undergo 
MV surgery after cardiac CT
•  26 patients who had diagnosis  
of infective endocarditis
•  1 patients with incomplete 
operation record
Fig. 1. Flowchart of study population. CT = computed tomography, MR = mitral regurgitation, MV = mitral valve
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MATERIALS AND METHODS
Patients
The Institutional Review Board of our institution 
approved this retrospective study and informed consent was 
waived. We enrolled 220 consecutive patients who were 
planned to receive MV surgery due to severe (grade 4) MR 
without significant mitral stenosis on echocardiography 
and were referred for cardiac CT for preoperative evaluation 
of the coronary artery and cardiac structures from January 
2014 to November 2016 (Fig. 1). Among these patients, we 
excluded 37 patients who did not undergo MV surgery (MV 
repair or replacement) after cardiac CT scan, 26 patients with 
infective endocarditis, and one patient with an incomplete 
operation record. We excluded patients with infective 
endocarditis because the criteria for the assessment of a non-
repairable valve (described in “Findings of a non-repairable 
valve”) could not be applied the same as in other etiologies, 
in the terms that extensive destruction of the valvular 
and subvalvular apparatus and rupture of the chordae 
tendineae would make repair impossible in patients with 
infective endocarditis (28). Finally, a total of 156 patients 
who underwent MV surgery after a cardiac CT scan due to 
severe MR from non-infective endocarditis were included. 
Demographic data and information regarding the MV surgery 
were collected from the electronic medical records. 
Fig. 2. CT images of repairable MV in 70-year-old female patient with degenerative MR.
Short-axis CT image of MV (A), CT images parallel to (B) and perpendicular to intercommissural axis (C), and three-dimensional volume-rendered 
image from surgeon’s view (D), showing prolapse of P2 scallop (arrow) without leaflet thickening or calcification, or mitral annular calcification. 
Patient underwent MV repair with ring annuloplasty. Ao = aorta, LAA = left atrial appendage
A B
C D
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CT Image Acquisition and Reconstruction
All cardiac CT scans were performed with a second 
generation dual-source CT scanner (SOMATOM Deﬁnition 
Flash, Siemens Healthineers, Forchheim, Germany). Before 
the contrast administration, non-enhanced calcium 
scoring images were acquired, and cardiac CT angiography 
was performed using the retrospective electrocardiogram 
(ECG)-gated data acquisition mode. Details of acquisition 
reconstruction are described in the Supplementary Materials 
(in the online-only Data Supplement). 
CT Image Analysis
All CT analyses were performed by one radiologist with 
6 years of experience with cardiac CT who was blinded to 
the clinical information. Assessment of the MV consisted of 
the evaluation of MV prolapse and leaflet morphology (Figs. 
2-4). The presence of MV prolapse and leaflet thickening 
was assessed using CT angiography with multiplanar 
reformatted images in a short-axis image of the MV annulus, 
a long-axis view of the LV, and a four-chamber view. MV 
prolapse was defined as leaflet displacement greater than 
2 mm below the annulus plane (Fig. 2), and assessed per 
patient, leaflet (anterior or posterior), and scallop (24). Per 
scallop evaluation of the prolapsed segment of the MV was 
assessed using the Carpentier classification (29). Bi-leaflet 
prolapse was defined as the presence of both anterior and 
posterior leaflet prolapse. For the evaluation of valve leaflet 
thickening, the maximal thickness of the MV leaflet was 
measured, and considered as thickened when the leaflet 
thickness was over 2 mm (24). Presence of MV leaflet 
calcification or MAC was assessed using the non-enhanced 
calcium scoring scan and CT angiography. For qualitative 
analysis, the presence of calcification was visually assessed. 
Quantitative assessment of MV leaflet calcification and 
MAC was performed by calculating the calcium score of the 
leaflet and mitral annulus separately using the Agatston 
scoring method (30).
Findings of a Non-Repairable Valve
We established findings of a non-repairable valve 
(requiring valve replacement) as those meeting the 
following conditions: 1) valve with anterior leaflet prolapse, 
2) valve with bi-leaflet prolapse, or 3) valve with non-
repairable morphology (24, 28, 31). Non-repairable valve 
morphology was considered when at least one of following 
findings was present: 1) leaflet thickening (> 2 mm), 2) MV 
leaflet calcification, or 3) MAC. Presence of these findings 
was assessed both on the preoperative cardiac CT and TTE.
Surgical Findings 
From the surgical records, the type of surgery (either MV 
replacement or repair) was investigated. The records for 
the prolapsed segments and morphology assessed during 
surgery were also obtained. Generally, intraoperative 
transesophageal echocardiography (TEE) was performed 
for the identification of the prolapsed MV segments and 
other abnormalities in the subvalvular structures of the 
MV. Moreover, the presence of MV prolapse and evaluation 
of valve morphology were confirmed by inspection during 
surgery. The surgical technique used for the correction 
of severe MR was also recorded, such as MV replacement, 
ring annuloplasty, leaflet resection, or chordae surgery 
Fig. 3. CT images of non-repairable MV in 46-year-old female patient showing bi-leaflet prolapse and leaflet thickening.
A, B. CT images of MV show bi-leaflet prolapse (arrows) and leaflet thickening. C. Three-dimensional volume-rendered image from surgeon’s view 
shows prolapse of both leaflets. Patient underwent MV replacement with tissue valve.
A B C
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(neochordae formation or chordae shortening).
TTE and TEE
TTE was performed before and after MV surgery as part 
of routine clinical practice using standard methods. LV 
assessment employed the parasternal long-axis view with 
two-dimensional direct measurements or guided M-mode 
at end-diastole and end-systole and measurement of the 
LV ejection fraction (32, 33). MR severity was assessed on 
a scale from 1 to 4 using Doppler echocardiography for a 
comprehensive MR assessment on the basis of specific and 
supporting signs of MR quantitation (34). The presence 
of anterior or bi-leaflet prolapse, and findings regarding 
non-repairable valve morphology (leaflet thickening or 
calcification or MAC) were assessed on preoperative TTE. 
In some cases, TEE was performed after TTE examination, 
especially when TTE provided non-diagnostic information 
about the severity of MR, mechanism of MR, and/or status 
of LV function. Postoperative follow-up echocardiographic 
examinations were performed after discharge in all but 
sixteen patients. The first Doppler echocardiographic study 
demonstrating moderate or severe MR was considered 
“recurrent MR” (19).
Statistical Analysis
Statistical analyses were performed using computerized 
statistics programs (MedCalc Statistical Software version 
18.9, MedCalc Software bvba, Ostend, Belgium; R, version 
3.5.1., R Foundation for Statistical Computing, Vienna, 
Austria). Normally distributed data were identified using 
the Shapiro-Wilk W test. Continuous variables are presented 
as the mean ± standard deviation and were compared using 
Fig. 4. CT images of non-repairable MV in 77-year-old female patient with degenerative MR, showing anterior leaflet prolapse, MV 
leaflet thickening and calcification, and mitral annular calcification.
(A, B) Short-axis CT images of MV show severe mitral annular calcification (arrows) and leaflet thickening. CT images parallel to (C) and 
perpendicular to intercommissural axis (D), and three-dimensional volume-rendered image of surgeon’s view (E) shows prolapse of A1 and A3 
scallops, thickening of MV leaflets, and leaflet calcification (arrow). Patient underwent MV replacement with tissue valve.
A B C
D E
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the independent t test for normally distributed data or 
Mann-Whitney U test for non-normally distributed data. 
Comparison of the distribution of the prolapsed segment 
and valve morphology according to the etiology of valvular 
heart disease was performed using the chi-square test or 
Fisher’s exact test. The diagnostic performance of cardiac 
CT for the detection of the prolapsed segment of the MV 
was assessed per patient, leaflet, and segment. Intra-
observer variability for CT findings of valve morphology was 
assessed using kappa statistics. Logistic regression analysis 
was performed to explore the value of each finding of non-
repairable MV to predict valve replacement (Supplementary 
Materials in the online-only Data Supplement). Otherwise, p 
values < 0.05 were considered statistically significant. 
RESULTS
Patients
The clinical characteristics of the study population are 
summarized in Table 1. Among the 156 patients, 18 patients 
(11.5%) had rheumatic MR and the remaining 138 patients 
(88.5%) had non-rheumatic MR. One hundred and eighteen 
patients (75.6%) underwent MV repair during corrective 
surgery for MR and the remaining 38 patients (24.4%) 
underwent MV replacement. After excluding 18 patients with 
a rheumatic etiology, 115 patients (83.3%) underwent MR 
repair and 23 patients (16.7%) underwent MR replacement.
CT Image Analysis
For the analysis of the detection of the prolapsed 
segment, two patients with congenital MR were excluded 
because segmentation of the MV scallop was difficult. In 
the remaining 154 patients, the diagnostic performance 
of cardiac CT for the detection of MV prolapse was as 
follows: sensitivity, 99.1%; specificity, 81.4%; positive 
predictive value, 93.2%; negative predictive value, 97.2%; 
and accuracy, 94.2% per patient (Table 2). Posterior 
leaflet prolapse was the most common location (60.5%) 
in degenerative disease (p < 0.001) (Table 3). Anterior 
leaflet prolapse was commonly seen in degenerative MR 
(p = 0.030). Leaflet thickening was most commonly seen 
in rheumatic MR (83.3%), followed by congenital (75%) 
and degenerative etiologies (53.1%, p = 0.028). Leaflet 
calcification was seen in 50% of cases of rheumatic and 
congenital MR, more frequently than in degenerative MR (p 
< 0.001), whereas MAC was seen in both rheumatic (22.2%) 
and degenerative MR (18.6%) at similar frequencies (p 
= 0.788). Intra-observer agreement ranged from good to 
excellent {kappa (95% confidence interval [CI]); 0.725 
(0.616–0.834) for leaflet thickening, 0.820 (0.681–0.960) 
for leaflet calcification, and 0.911 (0.824–0.997) for MAC}.
Findings of Non-Repairable Valve and Prediction of 
Actual Valve Replacement
Non-repairable MV was considered present in 117 cases 
based on CT image analysis and 88 cases based on TTE 
results (Table 3). Analysis by etiology found that rheumatic 
heart disease had a significantly higher proportion 
of non-repairable valves on CT than other etiologies, 
along with a subsequent higher percentage of patients 
receiving valve replacement. CT and TTE findings for the 
assessment of a non-repairable valve showed excellent 
agreement for anterior leaflet prolapse, moderate agreement 
for bi-leaflet prolapse, and poor agreement for valve 
morphology (Supplementary Table 1 in the online-only 
Data Supplement). For the diagnosis of each finding of 
non-repairable valve, CT tended to show higher sensitivity, 
specificity, and diagnostic accuracy for the detection of 
Table 1. Patient Characteristics and Information about MV 
Surgery
Characteristics Data (n = 156)
Male sex 77 (49.4)
Age* 59.9 (50.8–68.6)
Body surface area (m2)* 1.65 (1.53–1.83)
Etiology of MV disease†
Degenerative 129 (82.7)
Rheumatic 18 (11.5)
Congenital 4 (2.5)
Secondary 3 (3.2)
Information about MV surgery
MV replacement 38 (24.4)
MV repair 118 (75.6)
Ring annuloplasty 118 (100)
Leaflet resection
Triangular resection 27 (22.9)
Quadriangular resection 4 (3.4)
Wedge resection 13 (11.0)
Chordae surgery
Neochordae formation 42 (35.6)
Chordae shortening 3 (2.5)
Commissuroplasty 11 (9.3)
Miscellaneous 4 (3.4)
Except where indicated, data are number of patients, with 
percentages in parentheses. *Data are medians, with 25th–75th 
percentile range in parentheses, †Suggested based on preoperative 
study results. MV = mitral valve
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Table 2. Diagnostic Performance of Cardiac CT for Detection of MV Prolapse with Surgical Findings as Standard Reference
True-
Positive
True-
Negative 
False-
Positive 
False-
Negative 
Sensitivity Specificity 
Positive 
Predictive 
Value
Negative 
Predictive 
Value
Diagnostic 
Accuracy 
CT (n = 154) 
Patient 110 35 8 1 
110/111 
(99.1) 
35/43 
(81.4)
110/118 
(93.2)
35/36 
(97.2)
136/154 
(94.2)
Anterior leaflet 47 99 4 4
47/51 
(92.2)
99/103 
(96.1)
47/51 
(92.2)
99/103 
(96.1)
146/154 
(94.8)
A1 13 130 6 5 
13/18 
(72.2)
130/136 
(95.6)
13/19 
(68.4)
130/135 
(96.3)
143/154 
(92.9)
A2 18 122 4 10
18/28 
(64.3)
122/126 
(96.8)
18/22 
(81.8)
122/132 
(92.4)
140/154 
(90.9)
A3 22 121 5 6
22/28 
(78.6)
121/126 
(96.0)
22/27 
(81.5)
121/127 
(95.3)
143/154 
(92.9)
Posterior leaflet 73 74 7 0 
73/73 
(100)
74/81 
(91.4)
73/80 
(91.3)
74/74 
(100.0)
147/154 
(95.5)
P1 14 124 14 2
14/16 
(87.5)
124/136 
(89.9)
14/28 
(50.0)
124/126 
(98.4)
138/154 
(89.6)
P2 31 112 6 5
31/36 
(86.1)
112/118 
(94.9)
31/37 
(83.8)
112/117 
(95.7)
143/154 
(92.9)
P3 37 102 14 1 
37/38 
(97.4)
102/116 
(87.9)
37/51 
(72.5)
102/103 
(99.0)
139/154 
(90.3)
Per leaflet 120 173 11 4
120/1124 
(96.8)
173/184 
(94.0)
120/131 
(91.6)
173/177 
(97.7)
293/308 
(95.1)
Per segment 135 711 49 29
135/164 
(82.3)
711/760 
(93.6)
135/184 
(73.4)
711/740 
(96.1)
846/924 
(91.6)
Single scallop 
involvement
67 575 43 5
67/72 
(93.1)
575/618 
(93.0)
67/110 
(60.9)
575/580 
(99.1)
642/690 
(93.0)
Multi-scallop 
involvement
68 378 22 24
68/92 
(73.9)
378/400 
(94.5)
68/90 
(75.6)
378/402 
(94.0)
446/492 
(90.6)
Data are number of patients, with percentages in parentheses. CT = computed tomography 
Table 3. Distribution of Location of MV Prolapse and Valve Morphology According to Etiology 
Entire Group Degenerative Rheumatic Congenital Secondary P
CT findings
Anterior leaflet prolapse* 51/154 (33.1) 49/129 (38.0) 1/18 (5.6) 0/2 (0) 1/5 (20) 0.030
Posterior leaflet prolapse* 80/154 (51.9) 78/129 (60.5) 2/18 (11.1) 0/2 (0) 0/5 (0) < 0.001 
Bi-leaflet prolapse* 14/154 (9.1) 14/129 (10.9) 0/18 (0) 0/2 (0) 0/5 (0) 0.394
Leaflet thickening (> 2 mm) 87/155 (56.1) 68/128 (53.1) 15/18 (83.3) 3/4 (75) 1/5 (20) 0.028
Leaflet calcification 18/156 (11.5) 7/129 (5.4) 9/18 (50.0) 2/4 (50) 0/5 (0) < 0.001
MAC 29/156 (18.6) 24/129 (18.6) 4 (22.2) 0/4 (0) 1/5 (20) 0.783
TTE findings†
Anterior leaflet prolapse 63/155 (40.6) 59/128 (46.1) 4/18 (44.4) 0/4 (0) 0/5 (0) 0.016
Posterior leaflet prolapse 61/155 (39.4) 60/128 (46.9)  1/18 (5.6) 0/4 (0) 0/5 (0) 0.001
Bi-leaflet prolapse 22/155 (14.2) 22/128 (17.2)  0/18 (0) 0/4 (0) 0/5 (0) 0.144
Leaflet thickening, calcification or MAC 45/155 (29.0) 24/128 (18.8) 17/18 (94.4) 1/4 (25) 3/5 (60) < 0.001
Operation (replacement) 38/156 (24.4) 21/129 (16.3) 15/18 (83.3) 1/4 (25) 1/5 (20) < 0.001
Data are number of patients, with percentages in parentheses. *Two patients with congenital MR were excluded based on CT analysis 
because segmentation of MV scallops was difficult, †One patient had no TTE examination before surgery. MAC = mitral annular 
calcification, MR = mitral regurgitation, TTE = transthoracic echocardiography
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anterior leaflet or bi-leaflet prolapse than TTE, and higher 
sensitivity and lower specificity for the evaluation of non-
repairable morphology (Supplementary Table 2 in the 
online-only Data Supplement). These results did not change 
after adjusting for disease etiology. Preoperative TEE was 
performed in 83 patients (53.2%). On TEE results, findings 
of a non-repairable MV were considered to be present in 
55 patients (66.3%, 35 with anterior prolapse, 10 with 
bi-leaflet prolapse, and 36 with non-repairable valve 
morphology). 
In univariate logistic regression analysis, bi-leaflet 
prolapse and valve morphology on CT (leaflet thickening, 
leaflet calcification and MAC with calcium score > 27.5) 
were significant predictors for valve replacement; however, 
anterior leaflet prolapse was not a significant predictor 
(Table 4). Among findings of a non-repairable MV that was 
assessed on TTE, valve morphology was the only significant 
predictor. Female sex (odds ratio [OR], 3.68; 95% CI, 1.65–
8.26, p = 0.002), smaller body surface area (OR, 0.02; 95% 
CI, 0.002–0.190, p < 0.001), and rheumatic etiology (OR, 
25; 95% CI, 6.7–93.4, p < 0.001) were significant clinical 
variables predicting valve replacement. After adjusting for 
clinical variables, bi-leaflet prolapse and leaflet thickening, 
as well as leaflet calcification (calcium score > 5.6) on 
CT were independent factors associated with actual valve 
replacement. None of the TTE findings were a significant 
predictor after such adjustments. When the combination of 
CT findings of non-repairable morphology was evaluated, 
leaflet thickening combined with MAC was the only 
significant predictors, before and after adjustment. After 
excluding 18 patients with a rheumatic etiology, CT findings 
of bi-leaflet prolapse, leaflet thickening and MAC were 
significant predictors of valve replacement (Supplementary 
Table 3 in the online-only Data Supplement). When 
adjusting for clinical variables, CT findings of bi-leaflet 
prolapse, leaflet thickening, and MAC (calcium score > 17.2) 
Table 4. Logistic Regression Analysis for Prediction of Actual MV Replacement
Variables
Unadjusted Adjusted for Clinical Variables
OR (95% CI) P AUC OR (95% CI) P AUC 
CT findings
Anterior leaflet prolapse 0.67 (0.30–1.52) 0.337 0.542 1.44 (0.55–3.81) 0.460 0.842
Bi-leaflet prolapse 3.58 (1.14–11.00)* 0.026* 0.562* 8.63 (2.12–33.57)* 0.002* 0.861*
Valve morphology 
Leaflet thickening (leaflet thickness > 2 mm) 6.01 (2.34–15.45)* < 0.001* 0.686* 4.14 (1.39–12.40)* 0.011* 0.861*
Leaflet calcification
Presence of leaflet calcification 6.46 (2.29–18.22)* < 0.001* 0.615* 2.22 (0.56–8.77) 0.255 0.845
Leaflet calcium score (> 5.6) 11.61 (3.43–39.28)* < 0.001* 0.628* 5.37 (1.08–26.62)* 0.040* 0.845*
MAC
Presence of MAC 2.26 (0.96–5.36) 0.063 0.568 1.66 (0.58–4.73) 0.341 0.849
MAC calcium score (> 27.5) 3.29 (1.33–8.15)* 0.010* 0.590* 2.74 (0.90–8.38) 0.077 0.854
Combination of morphologic findings
Leaflet thickening + leaflet calcification 7.01 (2.18–22.53)* 0.001* 0.597* 3.53 (0.83–15.06) 0.088 0.846
Leaflet thickening + MAC 6.67 (2.23–19.90)* < 0.001* 0.606* 5.28 (1.45–19.15)* 0.011* 0.856*
Leaflet calcification + MAC 3.29 (0.63–17.01) 0.156 0.527 0.75 (0.08–6.79) 0.796 0.841
Leaflet thickening + leaflet calcification + MAC 
calcium score (> 27.5)
4.97 (0.80–30.95) 0.086 0.531 2.22 (0.24–20.92) 0.458 0.842
Leaflet thickening + leaflet calcium score (> 5.6) 10.22 (2.56–40.89)* 0.001* 0.593* 5.22 (0.93–29.39) 0.061 0.847
Leaflet thickening + MAC calcium score (> 27.5) 7.60 (2.14–26.95)* 0.002* 0.588* 6.88 (1.58–30.02)* 0.010* 0.849*
Leaflet calcium score (> 5.6) + MAC 2.13 (0.34–13.25) 0.418 0.514 0.21 (0.01–3.03) 0.251 0.844
Leaflet thickening + leaflet calcium score (> 5.6) 
+ MAC calcium score (> 27.5)
3.22 (0.44–34.70) 0.250 0.518 0.84 (0.06–12.87) 0.901 0.842
Preoperative TTE findings
Anterior leaflet prolapse 0.81 (0.38–1.72) 0.583 0.525 1.22 (0.48–3.09) 0.675 0.838
Bi-leaflet prolapse 1.18 (0.43–3.28) 0.746 0.511 2.05 (0.65–6.44) 0.219 0.835
Leaflet thickening, calcification or MAC 5.62 (2.55–12.37)* < 0.001* 0.691* 2.83 (0.97–8.26) 0.057 0.851
*Values indicate statistical significance. AUC = area under curve, CI = confidence interval, OR = odds ratio
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remained as independent predictors. 
Follow-Up Clinical Outcomes
During the mean follow-up interval of 599.8 ± 237.7 
days, 102 patients with MV repair had available follow-
up TTE examinations. Among these 102 patients, seven 
cases of recurrent MR (6.9%) were observed on the follow-
up TTE (Table 5). There was no significant difference in 
preoperative CT findings according to the presence of 
recurrent MR. Patients with recurrent MR showed a larger 
preoperative LV end-diastolic dimension than patients 
without recurrent MR (p = 0.040). Neither the type of 
surgical technique (ring annuloplasty only versus ring 
annuloplasty combined with other techniques) nor the 
etiology of MV disease was significantly different between 
the groups according to the presence of recurrent MR (p 
> 0.05). Only one patient underwent re-operation (MV 
replacement) due to recurrent MR during follow-up.
DISCUSSION
Our study demonstrates that cardiac CT can accurately 
detect MV prolapse in patients with severe MR and can 
predict a non-repairable MV. Among the findings for a non-
repairable MV, bi-leaflet prolapse and valve morphology 
defined as leaflet thickening, calcification, or MAC on CT 
were important determinants of a valve replacement. 
Among the MV findings that were considered as unsuitable 
for repair in our study, the anterior leaflet was not a critical 
component when selecting MV repair. Valve morphology 
was the most important predictor of valve replacement with 
the highest area under the curve on the logistic regression 
analysis. We speculate that this result may be because the 
surgeons at our institution have extensive experience in MV 
surgery and achieved a successful repair in cases of anterior 
prolapse (35). This result is consistent with findings from 
a previous study where an almost 100% repair rate was 
achieved for anterior or bi-leaflet prolapse in a high-volume 
reference center (6). 
Valve leaflet thickening and/or calcification can 
accompany leaflet restriction and is mostly seen in 
rheumatic valve disease, which favors MV replacement rather 
than repair. However, non-repairable leaflet morphology is 
not a pathognomonic finding for rheumatic heart disease, 
and non-rheumatic MV disease, such as myxomatous 
degeneration, can lead to leaflet thickening or calcification, 
which leads to unfavorable outcomes after MV repair is 
attempted. In addition, MAC can be seen in degenerative 
MV disease and sometimes results in MR or mitral stenosis 
and is considered to be less suitable for conventional MV 
repair due to poor postoperative outcomes (36-39). In 
our study, after exclusion of patients with a rheumatic 
etiology, valve morphology, such as leaflet thickening and 
the presence of MAC, remained an independent predictor 
of valve replacement, indicating the importance of valve 
morphology when planning MV surgery. Accordingly, careful 
preoperative evaluation of the valve morphology is crucial 
for both planning of surgery and predicting postoperative 
outcomes.
According to the current guidelines, a well-established 
indication of cardiac CT for valvular heart disease includes 
preoperative coronary artery evaluation (40-43). Indeed, 
most of our study population underwent cardiac CT for 
the main purpose of coronary artery evaluation before 
MV surgery. However, the excellent spatial resolution of 
cardiac CT is a great benefit in the evaluation of anatomical 
structures and geometry despite the inferior temporal 
resolution compared to other imaging modalities. A few 
previous studies using cardiac CT in MV disease focused 
on the evaluation of the diagnostic performance of cardiac 
CT for the detection of MV prolapse in degenerative MV 
disease, with sensitivity in the range of 84.6–96.2% and 
specificity in the range of 93.2–100% per patient (23-26). 
Table 5. Comparison of CT and TTE Findings According to 
Presence of Recurrent MR on Follow-Up
Recurrent MR Present (n = 7) Absent (n = 95)  P
CT
Anterior leaflet 
prolapse
3 (42.9) 30 (31.6) 0.844
Bi-leaflet prolapse 1 (14.3) 6 (6.3) 0.976
Leaflet thickening 
or calcification
1 (14.3) 11 (12.9) 0.700
TTE
Preoperative 
LVEDD (mm)
66 (61–71) 59 (53.8–63.3) 0.040*
Preoperative LVEF 
(%)
68 (63.3–72.8) 66 (60–73) 0.831*
Postoperative 
LVEDD (mm)
51.5 (49–68) 50 (46–54) 0.357*
Postoperative LVEF 
(%)
62 (57.3–4) 62 (57–65) 0.830*
Except where indicated, data are number of patients, with 
percentages in parentheses. *Data are medians, with 25th–75th 
percentile range in parentheses. LVEDD = left-ventricular end-
diastolic dimension, LVEF = left-ventricular ejection fraction
361
Cardiac CT for Mitral Regurgitation
https://doi.org/10.3348/kjr.2018.0350kjronline.org
Our study found a higher sensitivity (99.1%) but lower 
specificity (81.4%) than the previous studies. This may be 
explained by differences in patient characteristics such as 
the disease etiology and type of CT scanner used. 
Besides the detection and localization of MV prolapse, 
cardiac CT can be a useful modality for the morphologic 
evaluation of MV, as shown in our study. Although TTE 
can provide information regarding valve morphology, CT 
comprehensively evaluates each of the non-repairable 
MV findings, especially when TTE cannot give sufficient 
information. For example, leaflet calcification and MAC 
cannot only be visually assessed, but also can be measured 
quantitatively using Agatston scoring. In our study, CT 
showed higher sensitivity and specificity for the evaluation 
of the location of MV prolapse, and higher sensitivity 
and lower specificity for the evaluation of non-repairable 
morphology, than TTE. In particular, cardiac CT may be 
an effective and useful tool to evaluate MAC, both in the 
visualization of its extent and location and quantification 
by calcium scoring (44, 45). Furthermore, cardiac CT has 
been used for the geometric assessment of the MV apparatus 
and LV remodeling to help determine the mechanism of 
functional MR (27, 46). Other applications of cardiac CT 
for the MV include informing the decision on the approach 
in MV surgery (minimally invasive surgery or sternotomy) 
(47) and pre-procedural planning of transcatheter MV 
implantation (48-51). CT can be an alternative imaging 
technique for MV evaluation in patients with a suboptimal 
TTE window and those that have a contraindication to 
cardiac magnetic resonance imaging. Based on the results of 
our study, we expect that the application of cardiac CT can 
be extended to preoperative planning before MV surgery. 
Postoperative adverse outcomes include recurrent MR, 
which is associated with subsequent re-operation and 
cardiac death (11, 17-19). According to our study results, 
recurrent MR seems to be associated with LV geometry 
rather than the extent of MV prolapse or valve morphology. 
In our study, the LV end-diastolic dimension was larger in 
patients with recurrent MR in preoperative TTE, which was 
consistent with a previous study finding that recurrent 
MR in repair of degenerative MR was associated with 
adverse LV remodeling (19). Nevertheless, the influence of 
MV morphology and extent of MV prolapse should not be 
overlooked in the planning of MV surgery. 
Our study has several limitations. First, the rate of 
performing MV repair rather than replacement and successful 
postoperative repair rate depends on the experience of the 
surgeon and/or valve team (5, 6). Our study result may not 
be generalized to institutions with less experienced surgeons 
and/or small patient volumes. Second, a selection bias may 
exist, because we only included patients who underwent 
a preoperative cardiac CT scan before MV surgery due to 
severe MR and did not include all patients who received 
MV surgery. Third, we did not compare the diagnostic 
performance of TEE, considering a potential selection bias 
because TEE was performed in only 83 patients (53.2%) 
of our study population. Rather, we described the brief 
results of TEE findings for a non-repairable valve. Finally, 
the potential hazard of radiation exposure from CT scanning 
should not be overlooked. Although we applied dose 
reduction strategies, such as automatic tube potential 
selection and concurrent automatic exposure control of 
tube current, we used retrospective ECG-gating without 
ECG-based tube current modulation, which may lead to an 
increase in the radiation dose. Further attempts to modify 
imaging acquisition protocols via a single-beat prospective 
ECG-gated imaging acquisition, using a wide detector-row 
scanner or robust iterative reconstruction techniques, will 
be more appropriate in reducing the radiation dose in the 
CT evaluation of patients with valvular heart disease. 
In conclusion, cardiac CT can have high diagnostic 
performance in detecting MV prolapse and predicting MV 
replacement before surgery. Among the CT findings, bi-
leaflet prolapse and valve morphology features, such as 
leaflet thickening, calcification, or MAC, are the most 
important predictors of a non-repairable MV.
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